Skip to content

Serotyping and antimicrobial susceptibility testing of Salmonella enterica in 2020

Serotyping and antimicrobial susceptibility testing of Salmonella enterica in 2020

The information is for S. enterica culture isolates received during the designated year.

Serotypic name No. tested Sterile site specimens Non-sterile site specimens
Total Not susceptible % Total Not susceptible %
Ciprofloxacin Ceftriaxone Ciprofloxacin Ceftriaxone
Enteritidis 965 204 58.3% 2.0% 761 58.3% 1.2%
I 4:i:- 265 8 50.0% 0.0% 257 25.7% 7.8%
Typhimurium 153 10 60.0% 10.0% 143 90.9% 3.5%
Rissen 63 3 0.0% 33.3% 60 30.0% 0.0%
London 36 0 - - 36 61.1% 0.0%
Derby 28 3 100.0% 0.0% 25 56.0% 0.0%
Saintpaul 32 4 100.0% 0.0% 28 100.0% 14.3%
Goldcoast 29 1 100.0% 0.0% 28 85.7% 0.0%
Typhi 10 8 62.5% 0.0% 2 50.0% 0.0%
Braenderup 3 0 - - 3 33.3% 0.0%
Wandsworth 8 0 - - 8 87.5% 0.0%
Stanley 22 0 - - 22 18.2% 0.0%
Bareilly 15 0 - - 15 53.3% 0.0%
Meleagridis 0 0 - - 0 - -
Weltevreden 20 0 - - 20 10.0% 0.0%
I 19:g,s,t 1 0 - - 1 0.0% 0.0%
Give 0 0 - - 0 - -
Singapore 10 2 100.0% 0.0% 8 37.5% 0.0%
Reading 0 0 - - 0 - -
Kentucky 6 0 - - 6 83.3% 50.0%
Others 115 6 16.7% 0.0% 109 36.7% 9.2%


Remark:

Multiple strains may have been received from the same patient.